Top entities: China Pharma Holdings, NYSE American, Hainan Helpson Medical & Biotechnology.

What category does this event fall under?

Regulatory — classified as market inquiry.

What is the sentiment of coverage?

Aggregate sentiment score: -10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

China Pharma Holdings issued statement · NYSE American contacted China Pharma Holdings

Is this event still developing?

This is an active story, last updated Jul 21, 2026. Coverage continues to evolve.

Regulatory market inquiry

China Pharma unusual stock activity

Q: When did this event occur?

First reported Jul 15, 2026; last updated Jul 21, 2026.

Q: What is the market impact?

General. The unusual market activity and subsequent NYSE American inquiry may create uncertainty among investors, potentially affecting CPHI's stock price.

Analysis based on 8 articles · First reported Jul 15, 2026 · Last updated Jul 21, 2026

Sentiment

-10

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The unusual market activity and subsequent NYSE American inquiry may create uncertainty among investors, potentially affecting CPHI's stock price. However, the company's denial of any undisclosed material developments may mitigate negative sentiment.

Pharmaceuticals

Event Summary

China Pharma Holdings, Inc. (NYSE American: CPHI) experienced unusual market activity in its common stock on July 10, 13, 15, and 21, 2026. The NYSE American contacted the company in accordance with usual practice. China Pharma stated it is not aware of any material nonpublic information or business developments that would explain the recent trading activity. The company issued statements under Section 401(d) of the NYSE American Company Guide, cautioning shareholders and prospective investors to exercise care due to the volatility and to rely only on information in SEC filings and press releases.

Key Actions

80 China Pharma Holdings issued statement

70 NYSE American contacted China Pharma Holdings

Entities Involved

stock

China Pharma Holdings

China Pharma is the subject of the unusual market activity and NYSE American inquiry. The company has denied any undisclosed material developments, but the volatility may impact investor confidence.

Importance 100.0 Sentiment -10.0

exch

NYSE American

NYSE American contacted China Pharma regarding unusual market activity, following standard procedure. The exchange's role is regulatory and does not imply any wrongdoing.

Importance 50.0 Sentiment 0.0

priv

Hainan Helpson Medical & Biotechnology

Hainan Helpson is a wholly-owned subsidiary of China Pharma. The event does not directly affect it, but it may be indirectly impacted by any changes in the parent company's stock performance.

Importance 10.0 Sentiment 0.0

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard